Dr. Wolf-Dieter Heiss

Donau-Universität Krems

Publikationen (Auszug Forschungs­datenbank)

Bornstein, NM.; Guekht, A.; Vester, J.; Heiss, WD.; Gusev, E.; Hömberg, V.; Rahlfs, VW.; Bajenaru, O.; Popescu, BO.; Muresanu, D. (2018). Safety and efficacy of Cerebrolysin in early post-stroke recovery: a meta-analysis of nine randomized clinical trials. Neurol Sci, 39/4: 629-640

Heiss, WD (2018). Contribution of PET Imaging to Clinical Management of Gliomas. OBM Neurobiology, 2/3:1: 1-25

Heiss, WD. (2018). The Additional Value of PET in the Assessment of Cerebral Small Vessel Disease. J Nucl Med, 59(11):: 1660-1664

Lanzer, P.; Leigh, R.; Berry, C.; van de Hoef, T.; Heiss, WD.; et. al (2018). Salutary reperfusion is the ultimate target of STSegment Elevation Myocardial Infarction (STEMI) and Acute Ischemic Stroke (AIS) interventions and should be routinely assessed in standard clinical and research protocols. Card Res Med, 1: 20-34

Reimer, J.; Montag, C.; Schuster, A.; Moeller-Hartmann, W.; Sobesky, J.; Heiss, WD.; et. al. (2018). Is Perfusion MRI without Deconvolution Reliable for Mismatch Detection in Acute Stroke? Validation with 15O-Positron Emission Tomography. Cerebrovasc. Dis., 46 (1-2): 16-23

Vester, JC.; Guekht, A.; Heiss, WD. (2018). Letter by Vester et al Regarding Article, “Hope Dies Last—Evidence Again Fails to Support a Neuroprotectant: Cerebrolysin for Acute Ischemic Stroke”. Stroke, 48(12): e365

Heiss, W.D. (2016). Malignant MCA Infarction: Pathophysiology and Imaging for Early Diagnosis and Management Decisions. Cerebrovascular Diseases, 41(1-2) doi: 10.1159/000441627: 1-7

Heiss, W.D. (2016). Hybrid PET/MR Imaging in Neurology: Present Applications and Prospects for the Future. Journal of Nuclear Medicine, 57(7) doi: 10.2967/jnumed.116.175208. Epub: 993-5

Heiss, W.D.; Rosenberg, G.A.; Thiel, A.; Berlot, R.; de Reuck, J. (2016). Neuroimaging in vascular cognitive impairment: a state-of-the-art review. BMC Medicine, 3;14(1): 174

Heiss, WD.; Zaro Weber, O. (2016). Validation of MRI Determination on PET Measurements in Ischemic Stroke. Journal of Nuclear Medicine, pii: jnumed.116.185975. [Epub ahead of print]

Hossmann, K.A.; Heiss, W.D. (2016). History of the Letzte Wiese/Last Meadow Concept of Brain Ischemia. Stroke, 47(3) doi: 10.1161/STROKEAHA.115.010976: e46-50

Madai, VI.; Wood, CN.; Galinovic, I.; Grittner, U.; Heiss, W.D. et. al (2016). Clinical-Radiological Parameters Improve the Prediction of the Thrombolysis Time Window by Both MRI Signal Intensities and DWI-FLAIR Mismatch. Cerebrovascular Diseases, 42(1-2) doi: 10.1159/000444887: 57-65

Muresanu, DF.; Heiss, WD.; Hoemberg, V. (2016). Cerebrolysin and Recovery After Stroke (CARS): A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial. Stroke, 47(1) doi: 10.1161/STROKEAHA.115.009416.: 151-9

Schirrmacher, R.; Dea, M.; Heiss, W.D. et. al (2016). Which Aspects of Stroke Do Animal Models Capture? A Multitracer Micro-PET Study of Focal Ischemia with Endothelin-1. Cerebrovascular Diseases, 41(3-4) doi: 10.1159/000442997: 139-47

Zaro-Weber, O.; Moeller-Hartmann, W.; Siegmund, D. et. al (2016). MRI-based mismatch detection in acute ischemic stroke: Optimal PWI maps and thresholds validated with PET. Journal of cerebral blood flow, 1:271678X16685574. doi: 10.1177/0271678X16685574.

Heiss, W.D. (2016). The Place of Neuroimaging in the Assessment of Cerebral Small Vessel Disease. JAMA Neurological, 73(4) doi: 10.1001/jamaneurol.2015.4735: 378-9

Heiss, W.D. (2016). Imaging effects related to language improvements by rTMS. Restorative Neurology and Neurosciences, 11;34(4) doi: 10.3233/RNN-150631: 531-6

Brainin, M.; Tuomilehto, J.; Heiss, W.D.; Bornstein, N.M.; Bath, P.M.; Teuschl, Y.; et al. (2015). Post-stroke cognitive decline: an update and perspectives for clinical research. European Journal of Neurology, 222(2): 229-38

Amarenco, P.; Davis, S.; Jones, E.F.; Cohen, A.A.; Heiss, W.D.; Kaste, M.; et al. (2014). Clopidogrel plus aspirin versus warfarin in patients with stroke and aortic arch plaques. Stroke, 45(5): 1248-1257

Heiss, W.D. (2014). PET bei Gliomen. Eine Übersicht der aktuellen Literatur. Nuklearmedizin, 53(4): 163-171

Mehr laden
von

Vorträge (Auszug Forschungs­datenbank)

Pathophysiological Changes in the Development of Post-Stroke Dementia

14th Hangzhou International Molecular Imaging Conference, Hangzhou, China, 26.10.2018

Methods to improve the therapeutic window for rTPAThrombolysis

14th Congress of the Society for the Study of Neuroprotection and Neuroprotection, Costa del Sol, Spain , 04.10.2018

Safety and Efficacy of Cerebrolysin in Early Post-Stroke Recovery: A Meta-Analysis of Nine Randomized Clinical Trials.

25th International Mondsee Medical Meeting, Salzburg, Österreich, 14.09.2018

Should Closure of PFO be the Standard of Care in Patients with ESUS?

The 12th World Congress on Controversies in Neurology (CONy), Poland, 22.03.2018

The NORTHSTAR study: testing the booster effect of transcranial brain stimulation on speech & language therapy in post-stroke aphasia

University of Medicine and Pharmacie „Iuliu Hatieganu", Doctoral School, Cluj, 17.02.2018

Brain Protection and Recovery after Stroke: Results of a Large Meta-Analysis

Joint Symposium of Romanian Society of Neurology and European Federation of Neurorehabilitation, Bucharest, Romania, 17.02.2018

Molecular Imaging in the Differential Diagnosis of Vascular Dementia

University of Medicine and Pharmacie „Iuliu Hatieganu", Doctoral School, Cluj, Romania, 16.02.2018

Malignant Infarction

University of Medicine and Pharmacie „Iuliu Hatieganu", Doctoral School, Cluj,, 16.02.2018

Imaging in Early Ischemic Stroke

University of Medicine and Pharmacie „Iuliu Hatieganu", Doctoral School, Cluj, 16.02.2018

Imaging for Prediction of Recovery and Outcome after Stroke.

University of Medicine and Pharmacie „Iuliu Hatieganu", Doctoral School, Cluj, 16.02.2018

Pathophysiology of Ischemic Stroke

University of Medicine and Pharmacie „Iuliu Hatieganu", Doctoral School, Cluj, 16.02.2018

Imaging for Prediction of Recovery and Outcome after Stroke.

University of Medicine and Pharmacie „Iuliu Hatieganu“, Doctoral School, Cluj, 14.02.2018

PET Imaging in the Differential Diagnosis of Vascular Dementia

University of Medicine and Pharmacie „Iuliu Hatieganu“, Cluj, Romania , 28.11.2012

Imaging for Selection of Patients for Efficient Treatment

University of Medicine and Pharmacie „Iuliu Hatieganu“, Cluj, Romania, 27.11.2012

Pathophysiology of Ischemic Stroke in Man Imaging the Penumbra and Progressive Damage

University of Medicine and Pharmacie „Iuliu Hatieganu“, Cluj, Romania, 26.11.2012

Functional and Molecular Imaging with Positron Emission Tomography Introduction

University of Medicine and Pharmacie „Iuliu Hatieganu“, Cluj, Romania, 26.11.2012

Imaging the Penumbra: The Pathophysiologic Basis for Therapy of Ischemic Stroke

“Multimedia” Auditorium / UMF “Iuliu Hatieganu”, Cluj-Napoca, Romania, 22.11.2012

PET Imaging in the Differential Diagnosis of Vascular Dementia

7th International Congress on Vascular Dementia,Riga, 21.10.2012

Imaging the Penumbra: The Pathophysiologic Basis for Therapy of Ischemic Stroke

IV. National Congress of Neurologists Kharkiv, Ukraine, 04.10.2012

Current Status and Future Directions in Stroke Imaging

8th Hangzhou International Imaging Conference Hangzhou, 14.09.2012

Mehr laden
von
Zum Anfang der Seite

 

Zum Glossar

Diese Website verwendet Cookies zur Verbesserung Ihrer Nutzererfahrung, für analytische Zwecke zur Optimierung unserer Systeme und für Marketingmaßnahmen. Indem Sie auf „OK" klicken bzw. die Website weiter verwenden, stimmen Sie der Cookie-Nutzung zu. Mehr Information zum Datenschutz.

OK